GlassScriptPhysician profile
Todd B Mendelson
NPI 1902048291
$15,136.61
in general payments reported to CMS, 2019-2025
21 companies · $252 in 2025
The $252 reported for 2025 was less than what a typical Clinical Cardiac Electrophysiology provider received nationally (typical 2025 total: $2,477).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,116 · 2020: $7,112 · 2021: $689 · 2022: $1,529 · 2023: $3,387 · 2024: $1,053 · 2025: $252.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $2,667 · Food and Beverage: $2,024.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $2,666.90 |
| Food and Beverage | $2,024.41 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic Vascular, INC. | $6,979.84 | 2019-2020 | |
| Medical Device Business Services, INC. | $2,418.31 | 2023 | Carto 3 |
| Abbott Laboratories | $2,019.21 | 2019-2025 | Aveir, Amplatzer Amulet, Jot Dx |
| Biosense Webster, INC. | $1,500.87 | 2019-2024 | Carto 3, Qdot Micro Catheter |
| Boston Scientific Corporation | $637.57 | 2019-2023 | Watchman Flx |
| Medtronic, INC. | $492.45 | 2021-2025 | Cobalt Dr Mri Surescan, Linq II, Micra |
| Impulse Dynamics (USA) INC. | $303.05 | 2022-2025 | Optimizer, Optimizer |
| Biotronik INC. | $216.59 | 2021-2025 | Biomonitor |
| Elutia, INC. | $162.82 | 2019-2021 | |
| Atricure, INC. | $127.59 | 2022 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $65.10 | 2021-2025 | Lifevest |
| Sanofi-Aventis U.S. LLC | $34.07 | 2021-2023 | |
| Edwards Lifesciences Corporation | $26.79 | 2023 | Edwards Sapien 3 Ultra Transcatheter Heart Valve |
| Cvrx, INC. | $24.40 | 2024 | Barostim Neo System |
| Cardiva Medical, INC. | $23.48 | 2023 | Cardiva Vascade 6/7f Vcs |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $23.48 | 2024 | Ozempic, Rybelsus |
| Angiodynamics, INC. | $22.53 | 2021 | |
| Stryker Corporation | $19.98 | 2024 | N/A |
| Heartflow, INC. | $19.64 | 2025 | |
| Ge Healthcare | $18.84 | 2021 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Todd Mendelson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.